Portrai Inc.

Portrai Inc. is a leading biotechnology research company dedicated to revolutionizing drug and biomarker discovery through advanced spatial transcriptomics. Portrai Inc. empowers pharmaceutical and biotech companies by co-developing drugs with co-licensing opportunities and providing a cutting-edge Platform-as-a-Service (PaaS). With a keen focus on radioligand therapy and antibody-drug conjugates in oncology and brain diseases, Portrai Inc. is at the forefront of therapeutic innovation.

Located at B1F, ON571, 78-18 Dongsulla-gil, Jongno-gu, Seoul, 03136, KR, Portrai Inc. utilizes a novel approach combining AI pathology with spatial transcriptomics to deliver scalable solutions for companion diagnostics. PortraiTARGET identifies optimal target locations within tissues, enabling prioritized target development. PortraiDRUG & PortraiMIX visualize and quantify drug distribution within tissue slides, crucial for drug optimization and licensing. PortraiMOA reveals overall RNA expression changes to ascertain drug efficacy, while PortraiTME integrates H&E slide images with spatial transcriptomics data to select the right patients for targeted therapies.

Leveraging advanced technology and a commitment to excellence, Portrai Inc. is poised to significantly impact the pharmaceutical landscape. The team is dedicated to innovation and delivering high-value solutions to its partners. We invite the manager of Portrai Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.